Todd Baumgartner

Todd Baumgartner has extensive work experience in the field of analytical chemistry. Todd is currently working as a Senior Principal Scientist at Mirati Therapeutics since January 2022. Prior to this, they held the position of Principal Scientist, Analytical Chemistry at Neurocrine Biosciences from January 2020 to January 2022. Before that, they served as Principal Scientist, Analytical Chemistry at La Jolla Pharmaceutical Company from September 2016 to December 2019. Todd also worked as a Senior Scientist, Analytical Chemistry at Arena Pharmaceuticals from November 2005 to August 2016. Todd started their career at Pfizer as a Scientist, Analytical Chemistry from June 2000 to October 2005, and earlier worked as a QC Chemist at The Immune Response Corporation from June 1999 to July 2000.

Todd Baumgartner attended the University of California, Santa Cruz, where they obtained a Bachelor of Arts (B.A.) degree in Biology. Todd then pursued a Master of Science (M.S.) degree in Marine Science from the same university.